Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases

被引:0
|
作者
C. L. Hertz
S. L. Christiansen
L. Ferrero-Miliani
S. L. Fordyce
M. Dahl
A. G. Holst
G. L. Ottesen
R. Frank-Hansen
H. Bundgaard
N. Morling
机构
[1] University of Copenhagen,Section of Forensic Genetics, Department of Forensic Medicine, Faculty of Health and Medical Sciences
[2] Rigshospitalet,Department of Clinical Biochemistry
[3] Copenhagen University Hospital,The Unit for Inherited Cardiac Diseases, The Heart Centre
[4] University of Copenhagen,Section of Forensic Pathology, Department of Forensic Medicine, Faculty of Health and Medical Sciences
[5] Rigshospitalet,undefined
[6] Copenhagen University Hospital,undefined
[7] University of Copenhagen,undefined
来源
关键词
Sudden cardiac death; Sudden unexplained death; Next-generation sequencing; Screening; Genetic; Mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Sudden cardiac death (SCD) is responsible for a large proportion of sudden deaths in young individuals. In forensic medicine, many cases remain unexplained after routine postmortem autopsy and conventional investigations. These cases are called sudden unexplained deaths (SUD). Genetic testing has been suggested useful in forensic medicine, although in general with a significantly lower success rate compared to the clinical setting. The purpose of the study was to estimate the frequency of pathogenic variants in the genes most frequently associated with SCD in SUD cases and compare the frequency to that in patients with inherited cardiac channelopathies. Fifteen forensic SUD cases and 29 patients with channelopathies were investigated. DNA from 34 of the genes most frequently associated with SCD were captured using NimbleGen SeqCap EZ library build and were sequenced with next-generation sequencing (NGS) on an Illumina MiSeq. Likely pathogenic variants were identified in three out of 15 (20 %) forensic SUD cases compared to 12 out of 29 (41 %) patients with channelopathies. The difference was not statistically significant (p = 0.1). Additionally, two larger deletions of entire exons were identified in two of the patients (7 %). The frequency of likely pathogenic variants was >2-fold higher in the clinical setting as compared to SUD cases. However, the demonstration of likely pathogenic variants in three out of 15 forensic SUD cases indicates that NGS investigations will contribute to the clinical investigations. Hence, this has the potential to increase the diagnostic rate significantly in the forensic as well as in the clinical setting.
引用
收藏
页码:793 / 800
页数:7
相关论文
共 50 条
  • [41] Use of sanger and next-generation sequencing to screen for mosaic and intronic APC variants in unexplained colorectal polyposis patients
    Elsayed, Fadwa A.
    Tops, Carli M. J.
    Nielsen, Maartje
    Morreau, Hans
    Hes, Frederik J.
    van Wezel, Tom
    FAMILIAL CANCER, 2022, 21 (01) : 79 - 83
  • [42] Utility of Next-Generation Sequencing in the Workup and Diagnosis of Patients with Myelodysplastic Syndromes and Unexplained Cytopenias: A Single Institution Experience
    Carr, D.
    Murray, S.
    Bejar, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1140 - 1140
  • [43] Next-generation sequencing panel approach for the molecular diagnosis of neuromuscular diseases in Argentinian paediatric patients
    Foncuberta, E.
    Lubieniecki, F.
    Cavassa, E.
    Garcia, F.
    Piergrossi, N.
    Veneruzzo, G.
    Gravina, P.
    Monges, S.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S146 - S146
  • [44] Metagenomic next-generation sequencing (mNGS) for diagnostically challenging infectious diseases in patients with acute leukemia
    Garnica, Marcia
    Pierrotti, Ligia Camera
    de Oliveira, Paula Vanessa
    Mazzi, Mariana
    Chebabo, Alberto
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2021, 25 (02):
  • [45] Application of metagenomic next-generation sequencing technology for difficult lung lesions in patients with haematological diseases
    Liu, Nana
    Kan, Jianying
    Yu, Naihao
    Cao, Wenbin
    Cao, Jie
    Jiang, Erlie
    Feng, Jing
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (09) : 5245 - 5254
  • [46] Identification of Mutations in Candidate Genes in Patients with Globe Anomalies: A Targeted Next-Generation Sequencing Approach
    Dubey, Sushil
    Vijayalakshmi, Perumalsamy
    Kedia, Sharwan
    Sundaresan, Periasamy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [47] Next-Generation Sequencing of Connective Tissue Genes in Patients with Classical Ehlers-Danlos Syndrome
    Junkiert-Czarnecka, Anna
    Pilarska-Deltow, Maria
    Bak, Aneta
    Heise, Marta
    Latos-Bielenska, Anna
    Zaremba, Jacek
    Bartoszewska-Kubiak, Alicja
    Haus, Olga
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (04) : 1472 - 1478
  • [48] Targeted next-generation sequencing of candidate genes reveals novel mutations in patients with dilated cardiomyopathy
    Zhao, Yue
    Feng, Yue
    Zhang, Yun-Mei
    Ding, Xiao-Xue
    Song, Yu-Zhu
    Zhang, A-Mei
    Liu, Li
    Zhang, Hong
    Ding, Jia-Huan
    Xia, Xue-Shan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (06) : 1479 - 1486
  • [49] Mutation Spectrum of Six Genes in Chinese Phenylketonuria Patients Obtained through Next-Generation Sequencing
    Gu, Ying
    Lu, Kangmo
    Yang, Guanghui
    Cen, Zhong
    Yu, Li
    Lin, Lin
    Hao, Jing
    Yang, Zhigang
    Peng, Jiabao
    Cui, Shujian
    Huang, Jian
    PLOS ONE, 2014, 9 (04):
  • [50] A Next-Generation Sequencing of the NOTCH3 and HTRA1 Genes in CADASIL Patients
    Angela Fernández
    Juan Gómez
    Belén Alonso
    Sara Iglesias
    Eliecer Coto
    Journal of Molecular Neuroscience, 2015, 56 : 613 - 616